Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04663672 · ClinicalTrials.gov registry record · NA
Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy
A NA study of Obsessive - Compulsive Disorder and Claustrophobia, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
- 1
- Study location
NCT04663672: Completed NA study of Obsessive - Compulsive Disorder and Claustrophobia, sponsored by University of Texas at Austin.
NCT04663672 is a NA study of Obsessive - Compulsive Disorder and Claustrophobia that has completed, run by University of Texas at Austin. The registered enrollment target is 158 participants, below the 2,063-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04663672, a NA study of Obsessive - Compulsive Disorder and Claustrophobia, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates whether a scent applied during exposure therapy and during subsequent sleep will increase the durability of treatment effects for individuals with fear of spiders, contamination, and enclosed spaces.
Primary Outcome
Change in subjective units of distress (0 = no fear, to 100 = extreme fear) and skin conductance in response to approaching a feared stimulus, from baseline to one month follow-up
Conditions Studied
Interventions
- OTHER Experimental Scent
- OTHER Control Scent
- OTHER No-Scent Control
- BEHAVIORAL In-Vivo Exposure
Study Locations (1)
Texas
- Laboratory for the Study of Anxiety Disorders, University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
What the finished NCT04663672 record still lists
NCT04663672 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 2,063-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 4 interventions - of which Experimental Scent is the first listed.
NCT04663672 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04663672 about?
NCT04663672 is a clinical study titled "Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy". This study evaluates whether a scent applied during exposure therapy and during subsequent sleep will increase the durability of treatment effects for individuals with fear of spiders, contamination, and enclosed spaces.
What is the current status of trial NCT04663672?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2019-01-29. Estimated completion is 2020-03-01.
What conditions does trial NCT04663672 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder, Claustrophobia, Arachnophobia.
What interventions are being tested in trial NCT04663672?
The interventions under investigation include: Experimental Scent (OTHER), Control Scent (OTHER), No-Scent Control (OTHER), In-Vivo Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04663672?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04663672 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04663672's enrollment target sits among peer trials
158 20th of 84 higher than 65 of 84 other Obsessive - Compulsive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obsessive - Compulsive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
-
Mechanisms of Exposure Therapy for OCD
RECRUITING · NA
-
Using Personalized Assessments in the Treatment of Childhood OCD
RECRUITING · NA
-
Neural Mechanisms of Response Inhibition Training for OCRD
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Interpretation Bias as a Mechanism of Treatment Response in OCD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI